A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease
Genevieve M. Leyden, View ORCID ProfileTom R. Gaunt, View ORCID ProfileTom G. Richardson
doi: https://doi.org/10.1101/2020.02.16.20023010
Genevieve M. Leyden
1MRC Integrative Epidemiology Unit, University of Bristol
2Bristol Medical School: Translational Health Sciences, University of Bristol
BScTom R. Gaunt
1MRC Integrative Epidemiology Unit, University of Bristol
PhDTom G. Richardson
1MRC Integrative Epidemiology Unit, University of Bristol
PhDArticle usage
Posted February 20, 2020.
A factorial Mendelian randomization study to systematically prioritize genetic targets for the treatment of cardiovascular disease
Genevieve M. Leyden, Tom R. Gaunt, Tom G. Richardson
medRxiv 2020.02.16.20023010; doi: https://doi.org/10.1101/2020.02.16.20023010
Subject Area
Subject Areas
- Addiction Medicine (405)
- Allergy and Immunology (716)
- Anesthesia (210)
- Cardiovascular Medicine (2992)
- Dermatology (254)
- Emergency Medicine (447)
- Epidemiology (12881)
- Forensic Medicine (12)
- Gastroenterology (840)
- Genetic and Genomic Medicine (4677)
- Geriatric Medicine (428)
- Health Economics (737)
- Health Informatics (2974)
- Health Policy (1079)
- Hematology (396)
- HIV/AIDS (942)
- Medical Education (434)
- Medical Ethics (116)
- Nephrology (479)
- Neurology (4457)
- Nursing (239)
- Nutrition (654)
- Oncology (2319)
- Ophthalmology (659)
- Orthopedics (261)
- Otolaryngology (330)
- Pain Medicine (289)
- Palliative Medicine (85)
- Pathology (506)
- Pediatrics (1208)
- Primary Care Research (506)
- Public and Global Health (7055)
- Radiology and Imaging (1565)
- Respiratory Medicine (927)
- Rheumatology (447)
- Sports Medicine (389)
- Surgery (495)
- Toxicology (60)
- Transplantation (214)
- Urology (186)